A deal at an early stage
According to the sources, Rho Nutrition has hired Rothschild & Co to find potential buyers. Both Rho and the bank declined to comment, and there is no guarantee a deal will be reached.
With expected revenue of around $200 million this year, a valuation above $500 million reflects market expectations for the growth of emerging health brands, especially those selling directly to consumers.
Liposomes and the brand story
Rho was founded in 2022 by supplement industry veterans Ryan Bishop and George Padilla. Its products target needs including cellular, skin, hair, brain, heart and hormonal health.

















